Livia Yap
Stories by Livia Yap
Yangon bourse targets turnaround this year to attract foreign investors
Last year, Myanmar passed a new Companies Law that says foreign investors can own as much as 35 percent of local firms.
Will the delisting trend actually turn out to be a good sign for SGX?
It creates a situation in which unlisted companies, free of the constraints of quarterly reporting, are more able to focus on long-term growth, thereb
Singapore tycoon Ron Sim suspends V3 Group’s HK listing plan amid market rout
The Singapore entrepreneur took Osim International Ltd private in a $236 million buyout in 2016. V3 Group comprises the Osim business and other consum
Men-only corporate boardrooms alive and well in China, Japan
Japanese companies without any female directors include SoftBank Group, Nintendo, Uniqlo and 7-Eleven while Chinese companies with no women on their b
This Singapore entrepreneur quit own venture in rare display of succession planning
So serious is the problem that succession planning has taken off as an industry in Singapore and elsewhere in Asia, with everyone from PE funds to M&A
From telegraph to video games, 139-year-old Singtel reinvents itself for millennials
The foray into gaming is its strategy to diversify from traditional businesses where competition is toughening.
Singtel partners Razer, Sea to launch Asia e-sports league in digital content push
Singtel, which has a market capitalization of about $40 billion, has sought to grow in new industries as competition encroaches on its traditional bus
Singapore’s MyRepublic mulls HK IPO as early as December 2019
Sixteen Singapore-based companies chose to list in Hong Kong last year, raising more than $800 million.
Singtel seeks to create platform to tap 50m users making mobile payments in Asia
Singtel plans to expand the platform to include mobile wallets provided by associates such as those in the Philippines, India and Indonesia,
Genting-backed Singaporean pharma startup TauRx claims $2.5b valuation
Funded by investors including casino operator Genting, TauRx Pharmaceuticals is embarking on its latest trial to find a cure for Alzheimer's.